The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)

NCT00894530 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharitis

Interventions

DRUG: Azithromycin ophthalmic solution, 1%
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC